Horizon Therapeutics

Youtube Subscribe

Open: 115.56 Close: 115.61 Change: 0.05

Stop waiting time to find out about Horizon Therapeutics Company Inc: Our AI summarizes all info about it.

How much time have you spent trying to decide whether investing in Horizon Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Horizon Therapeutics are: …

Concept Map

Semantic Network

Stock Summary

Horizon Therapeutics Public Limited Company focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Its portfolio comprises 12 medicines in the areas of rare diseases.

Today's Summary

Federal Trade Commission cleared Amgen to proceed with its $27.8 billion acquisition of Horizon Therapeutics. Percentage of shares that are sold short has grown since its last report.

Today's News

Percentage of shares that are sold short for Horizon Therapeutics has grown since its last report. The company has more short interest than most of its peers. Horizon Therapeutics Public Limited Limited Company (HZNP) Stock Price, News, Quote & History - Yahoo Finance Home Mail News Finance Sports Entertainment and Sports Entertainment. Horizon Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences. Analysts estimate an earnings decrease this quarter of$0.21 per share, a decrease next quarter of $0.01 per share and an increase next year of$1.31 per share. Federal Trade Commission cleared Amgen to proceed with its $27.8 billion acquisition of Horizon Therapeutics. FTC had filed a lawsuit in May seeking to block the acquisition, arguing that the deal would stifle competition in the pharmaceutical industry. Amgen, a massive biopharmaceutical company, had a deal to acquire Horizon Therapeutics (the maker of Tepezza) for $116.50 per share. The Federal Trade Commission reached a proposed consent order with Amgen Inc. to address potential competitive harm.

Stock Profile

"Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; Arrowhead Pharmaceuticals, Inc.; Q32 Bio Inc.; and Xeris Biopharma Holdings, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland."

Keywords

Are looking for the most relevant information about Horizon Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Horizon Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Horizon Therapeutics are: share, Horizon, Therapeutics, Amgen, short, company, Limited, and the most common words in the summary are: horizon, therapeutic, news, watch, introduction, episode, rightarrow, . One of the sentences in the summary was: Percentage of shares that are sold short has grown since its last report.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #horizon #therapeutic #news #watch #introduction #episode #rightarrow.

Read more →

Youtube Subscribe

---